Technetium-99M全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計Technetium-99m的市場規模將從2025年的71.1億美元成長到2034年的101億美元，2026年至2034年的複合年成長率為3.97%。

由於Technetium-99m在核子醫學掃描術診斷的廣泛應用，其全球市場在醫療領域的重要性日益凸顯。Technetium-99m是一種放射性同位素，常用於骨骼掃描、心臟影像影像和癌症篩檢等診斷程序。其半衰期短且成像清晰，使其成為醫學診斷中最常用的同位素之一。

多種因素正在推動Technetium-99m市場的成長。對精準診斷影像和疾病早期檢測日益成長的需求，正在擴大核子醫學技術的應用範圍。此外，影像設備和放射性藥物生產技術的進步，也提高了基於Technetium的診斷程序的可及性和有效性。

未來幾年，隨著醫療系統將早期診斷和疾病管理置於優先地位，Technetium-99m市場預計將持續成長。核子醫學和放射性藥物技術的探索有望提高診斷影像的準確性和病人安全。此外，發展中地區醫療基礎設施的擴建預計將增加核醫診斷檢測的可近性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球Technetium-99M市場：依臨床服務分類

• 市場分析、洞察與預測
• 骨骼掃描
• 腎臟掃描
• 心臟掃描
• 神經系統掃描

第5章：全球Technetium-99m市場：依同位素應用分類

• 市場分析、洞察與預測
• 伽馬攝影機
• 單光子發射電腦斷層掃描（SPECT）

第6章：全球Technetium-99M市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷中心
• 其他

第7章：全球Technetium-99M市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Advanced Accelerator Applications SA
  • Advanced Cyclotron SystemsInc
  • Bayer AG
  • GE Healthcare
  • Philips Healthcare,
  • Siemens Healthineers
  • Eckert & Ziegler
  • IBA Radiopharma Solutions
  • Medi-Radiopharma Kft
  • Lantheus HoldingsInc
  • NordionInc
  • NTP Radioisotopes SOC Ltd
  • Jubilant Life Sciences
  • SDS Lifesciences Pvt. Ltd
  • BWX TechnologiesInc

The Technetium-99m Market size is expected to reach USD 10.10 Billion in 2034 from USD 7.11 Billion (2025) growing at a CAGR of 3.97% during 2026-2034.

The global technetium-99m market has gained importance in the healthcare sector due to its widespread use in nuclear medicine imaging. Technetium-99m is a radioactive isotope commonly used in diagnostic procedures such as bone scans, cardiac imaging, and cancer detection. Its short half-life and ability to produce clear imaging results make it one of the most widely used isotopes in medical diagnostics.

Several factors are driving the growth of the technetium-99m market. Increasing demand for accurate diagnostic imaging and early disease detection has expanded the use of nuclear medicine technologies. Additionally, advancements in imaging equipment and radiopharmaceutical production have improved the availability and effectiveness of technetium-based diagnostic procedures.

In the coming years, the technetium-99m market is expected to continue growing as healthcare systems prioritize early diagnosis and improved disease management. Research in nuclear medicine and radiopharmaceutical technologies may enhance imaging accuracy and patient safety. Furthermore, expanding healthcare infrastructure in developing regions will likely increase access to nuclear diagnostic procedures.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Clinical Services

• Bone Scan
• Renal Scan
• Cardiac Scan
• Neurology Scan

By Isotopic Application

• Gamma Camera
• Single Photon Emission Computed Tomography (SPECT)

By End User

• Hospitals
• Diagnostic Centers
• Others

COMPANIES PROFILED

• Advanced Accelerator Applications SA, Advanced Cyclotron Systems, Inc, Bayer AG, GE Healthcare, Philips Healthcare,, Siemens Healthineers, Eckert Ziegler, IBA Radiopharma Solutions, MediRadiopharma Kft, Lantheus Holdings, Inc, Nordion, Inc, NTP Radioisotopes SOC Ltd, Jubilant Life Sciences, SDS Lifesciences Pvt Ltd, BWX Technologies, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TECHNETIUM-99M MARKET: BY CLINICAL SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Clinical Services
• 4.2. Bone Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Renal Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cardiac Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Neurology Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TECHNETIUM-99M MARKET: BY ISOTOPIC APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Isotopic Application
• 5.2. Gamma Camera Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Single Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TECHNETIUM-99M MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TECHNETIUM-99M MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Clinical Services
  • 7.2.2 By Isotopic Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Clinical Services
  • 7.3.2 By Isotopic Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Clinical Services
  • 7.4.2 By Isotopic Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Clinical Services
  • 7.5.2 By Isotopic Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Clinical Services
  • 7.6.2 By Isotopic Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TECHNETIUM-99M INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Advanced Accelerator Applications S.A
  • 9.2.2 Advanced Cyclotron SystemsInc
  • 9.2.3 Bayer AG
  • 9.2.4 GE Healthcare
  • 9.2.5 Philips Healthcare,
  • 9.2.6 Siemens Healthineers
  • 9.2.7 Eckert & Ziegler
  • 9.2.8 IBA Radiopharma Solutions
  • 9.2.9 Medi-Radiopharma Kft
  • 9.2.10 Lantheus HoldingsInc
  • 9.2.11 NordionInc
  • 9.2.12 NTP Radioisotopes SOC Ltd
  • 9.2.13 Jubilant Life Sciences
  • 9.2.14 SDS Lifesciences Pvt. Ltd
  • 9.2.15 BWX TechnologiesInc